Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome

Mario Sa1, Luwaiza Mirza1, Michael Carter1

  • 1From the Children's Neurosciences (M.S., V.G., T.H., K.L., J.-P.L., D.L., T.R., R.S., S.T., S.B., M.L.), Paediatric Intensive Care (M.C., J.H., J.K., M.M.), Department of Paediatric Neuroradiology (L.C.J., A.S.), Department of Congenital Heart Disease (O.M.), Department of Pediatric Rheumatology (V.S.), and Department of General Paediatrics (M.W.), Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust; Department of Women and Children's Health (L.M., M.C., J.H., J.K., O.M., M.W., M.L.), School of Life Course Sciences, King's College London; and Department of Neuroradiology (L.C.J., A.S.), King's College Hospital, London, United Kingdom.

Summary

Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) can cause serious neurologic issues in children. Higher inflammatory markers in PIMS-TS patients with neurologic symptoms indicate a poorer prognosis.